Driehaus Capital Management LLC United Therapeutics Corp Transaction History

Driehaus Capital Management LLC

  • $10.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$205.95 - $280.43 $1.65 Million - $2.25 Million
8,006 Added 21.11%
45,933 $12.8 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $1.39 Million - $1.67 Million
-6,841 Reduced 15.28%
37,927 $7.94 Million
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $7.83 Million - $10.8 Million
44,768 New
44,768 $10.5 Million

Others Institutions Holding UTHR

# of Institutions
669
Shares Held
42.8M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email